Tobacco giant Philip Morris International (PMI) has bought a 22.61 percent stake in British asthma inhaler maker Vectura. Following the deal, PMI announced that it plans to continue acquiring Vectura shares on the market at 165p (RUB167) per share. informs CNBC.
PMI is interested in Vectura, as it believes that in the future, the acquisition of the company will allow it to earn more. The cigarette maker is counting on the absorption of Vectura, intending increase their revenues from the sale of goods and services not related to nicotine, up to a billion dollars a year. It is assumed that PMI will gain access to inhaler technologies for the production of alternative smoking systems, however, the production of the asthma drugs Vectura will continue after the takeover.
Read Also
- TikTok users become a prime target of crooks Sep 13, 2020
- On iPad Pro M1, apps can only use 5GB of RAM May 28, 2021
- Delta Italia variant and yellow zone, divided experts Jul 12, 2021
- “Identity and Nationality” announces the extension of working hours in 3 customer happiness centers Aug 28, 2021
- Mass resignations at Twitter after Elon Musk’s ultimatum, network infrastructure threatened Nov 19, 2022
- The trick to change the color of WhatsApp: how to activate it Aug 16, 2021
- Arcom challenges Twitter and expresses “deep concern” over fake news and online hate Nov 21, 2022